Updated:
GSK Venture Fund
GSK Venture Fund is the family office of Gil Simon, established to manage the private investment activity generated by his career in technology-focused...
GSK Venture Fund
GSK Venture Fund is the family office of Gil Simon, established to manage the private investment activity generated by his career in technology-focused asset management. Simon co-founded SoMa Equity Partners in 2013 after serving as a portfolio manager at Galleon Group, where he specialized in technology, media, and telecommunications equities. The venture fund reflects that lineage, concentrating on sectors where Simon's public-market experience provides a structural edge in evaluating private company trajectories. The fund targets early-stage investments across enterprise software, fintech, digital health, and consumer internet. Its geographic focus is concentrated in the United States, with deal activity flowing through its offices in the Bay Area, Austin, and New York. The vehicle invests Simon's personal capital, which allows for flexible check sizes and a lack of institutional fundraising constraints. The fund has participated in rounds alongside top-tier venture firms, though a full list of direct holdings is not publicly disclosed. Team size and total deployed capital remain private. The firm's multiple-office footprint — spanning Menlo Park, Palo Alto, San Francisco, Santa Clara, Austin, and New York — suggests a distributed network of investment professionals or advisors rather than a large centralized staff. The fund's presence in both Northern and Southern California tech hubs, as well as the Austin and New York ecosystems, positions it to source deals across distinct founder and co-investor networks. Simon's background as a hedge fund manager rather than a traditional venture capitalist gives GSK Venture Fund a public-market-informed lens on private investing. The firm's long-only technology experience at SoMa Equity Partners, combined with the long/short discipline developed at Galleon Group, informs a valuation-conscious approach to venture that distinguishes it from returns-insensitive family offices. The structure as a single-family office with no external investors also removes the pressure to deploy capital on a fixed timeline, allowing the firm to be highly selective in entering competitive rounds.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
Austin, TX · New York, NY · Santa Clara, CA · Palo Alto, CA · San Francisco, CA
Principals
Gil Simon
Founder and Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at GSK Venture Fund?
Gil Simon, the founder and managing partner, leads all investment decisions for the fund. Simon's investment career spans two decades, including roles as a portfolio manager at Galleon Group and co-founding the technology-focused hedge fund SoMa Equity Partners in 2013. His public-market technology investing background shapes the fund's venture strategy and decision-making framework.
How does GSK Venture Fund source proprietary deal flow?
The firm sources deals primarily through Simon's professional network developed over two decades in technology investing. Its physical presence across six offices — Menlo Park, Palo Alto, San Francisco, Santa Clara, Austin, and New York — provides access to distinct founder communities and co-investor relationships in the Bay Area, Texas, and East Coast technology corridors. The fund's ability to move quickly as a personal-capital vehicle also makes it an attractive partner for founders seeking efficient closes.
Is GSK Venture Fund structured as a single family office or does it operate more like a venture firm?
GSK Venture Fund is structured as a single family office managing Gil Simon's personal capital, not an institutional venture fund raising outside LP commitments. This structure provides notable flexibility in check sizes, holding periods, and decision velocity. Unlike a traditional venture firm, the fund does not face deployment pressure from limited partners or fixed fund-life constraints.
Does GSK Venture Fund participate in fund commitments or only direct deals?
The fund's primary activity is direct investments in early-stage technology companies, consistent with its principal-driven, concentrated approach. While the exact portfolio composition is private, the fund's family office structure suggests a preference for direct exposure to individual companies rather than broad fund-of-fund commitments, though select GP relationships may exist as part of Simon's broader investment network.
What investment stages does GSK Venture Fund typically target?
The fund focuses on early-stage investments, including seed and Series A rounds, where Simon's technology-sector expertise and flexible capital can be most differentiating. The vehicle does not publicly disclose stage-specific allocation targets, but its angel-oriented, principal-driven model is best suited to early entry points with long holding periods.
How is GSK Venture Fund related to SoMa Equity Partners?
GSK Venture Fund and SoMa Equity Partners are distinct entities but share the same founder, Gil Simon. SoMa Equity Partners is a technology-focused long-only hedge fund founded in 2013 that Simon continues to lead. GSK Venture Fund represents Simon's private-market investment activity, housed in a separate family office structure. The two entities benefit from shared sector expertise but have separate mandates and capital bases.
What is GSK Venture Fund's known posture on co-investments alongside external GPs?
The fund has participated in financing rounds alongside established venture capital firms, leveraging Simon's reputation and network to access competitive deals. As a personal-capital vehicle, GSK Venture Fund typically takes minority positions and does not lead rounds, instead partnering with larger institutional VCs who set terms and conduct primary due diligence. Specific co-investment partners have not been publicly catalogued.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: